keyword
MENU ▼
Read by QxMD icon Read
search

meta AND biliary tract

keyword
https://read.qxmd.com/read/30797051/18f-fluorodeoxyglucose-positron-emission-tomography-18fdg-pet-for-patients-with-biliary-tract-cancer-systematic-review-and-meta-analysis
#1
Angela Lamarca, Jorge Barriuso, Amarjot Chander, Mairéad G McNamara, Richard A Hubner, Derek O'Reilly, Prakash Manoharan, Juan W Valle
INTRODUCTION: The role of 18 F-fluorodeoxyglucose positron emission tomography (18 FDG-PET) in the diagnosis and staging of patients with biliary tract cancer (BTCs) remains controversial. METHODS: This systematic-review and meta-analysis explored the diagnostic test accuracy (DTA) of 18 FDG-PET as a diagnostic tool for diagnosis of primary tumour (T), lymph node (N), distant metastases (M) and relapsed disease (Rel). Subgroup analysis by study quality and BTC subtype were performed...
February 20, 2019: Journal of Hepatology
https://read.qxmd.com/read/30753687/effects-of-aspirin-and-non-steroidal-anti-inflammatory-drugs-on-the-risk-of-cholangiocarcinoma-a-meta-analysis
#2
Kamolyut Lapumnuaypol, Andrew Tiu, Charat Thongprayoon, Karn Wijarnpreecha, Patompong Ungprasert, Michael A Mao, Wisit Cheungpasitporn
Background: Nonsteroidal anti-inflammatory drugs (NSAIDs) can suppress the proliferation of cholangiocarcinoma (CCA) cells in vitro through inhibition of cyclooxygenase-2. However, the effects of aspirin and NSAIDs on the risk of CCA remain unclear. We performed this meta-analysis to assess the risk of biliary tract cancers in patients who take aspirin and/or NSAIDs. Methods: A systematic review was conducted utilizing MEDLINE, EMBASE, Cochrane databases from inception through October 2017 to identify studies that assessed the association of aspirin and/or NSAIDs use with risk of biliary tract cancers including CCA, gallbladder cancer, and ampulla of Vater cancer...
February 7, 2019: QJM: Monthly Journal of the Association of Physicians
https://read.qxmd.com/read/30662546/the-efficacy-and-safety-of-first-line-chemotherapies-for-advanced-biliary-tract-cancer-a-network-meta-analysis
#3
Wei Zheng, Jie Ying, Yan Zhou, Zhiwen Lu, Ke Min, Weimin Wang, Yun Zhang, Miao Zhang, Jian Yang
Major chemotherapeutic drugs for advanced biliary tract cancer (ABTC) include gemcitabine, fluoropyrimidines and platinum compounds, but the optimum combination of them remains inconclusive. The main objective of this network meta-analysis was to compare the efficacy and safety of first-line chemotherapies for ABTC. Methods: We searched PubMed, EMBASE, the Cochrane library and Science Direct for relevant controlled trials until May 2017. We estimated the Hazard ratios (HRs) for survival time and odds ratios (ORs) for response rate and toxic effects among different therapies...
2019: Journal of Cancer
https://read.qxmd.com/read/30633169/efficacy-and-safety-of-yinchen-sini-decoction-in-treating-biliary-atresia-patients-after-kasai-portoenterostomy-a-systematic-review-and-meta-analysis-protocol
#4
Guoming Chen, Chuyao Huang, Jiaxin Lu, Ruilan Huang, Jie Zhang, Ziyin Chen, Hua Xu
BACKGROUND: Biliary atresia (BA) is a neonatal obstructive biliary tract disease in which the intrahepatic and extrahepatic bile ducts are obstructed and can lead to congenital biliary atresia of cholestatic cirrhosis and eventually liver failure. It has been confirmed that the Kasai portoenterostomy is an effective treatment for BA. But most patients still face complications, such as cholangitis and liver fibrosis. Yinchen Sini decoction (YCSND), a traditional herbal formula, is used as a treatment for BA after Kasai portoenterostomy...
January 2019: Medicine (Baltimore)
https://read.qxmd.com/read/30612929/kml001-an-arsenic-compound-as-salvage-chemotherapy-in-refractory-biliary-tract-cancers-a-prospective-study
#5
Jung Hyun Jo, Huapyong Kang, Hee Seung Lee, Moon Jae Chung, Jeong Youp Park, Seungmin Bang, Seung Woo Park, Si Young Song
BACKGROUND: Sodium meta-arsenite (NaAsO2 , KML001) is a potential oral anticancer agent acting on telomerase and telomere length. This prospective study evaluated its safety, tolerability, and effectiveness as salvage chemotherapy in patients with advanced biliary tract cancer (BTC) resistant to gemcitabine-based chemotherapy. METHODS: Forty-four patients (21 women and 23 men) with advanced BTC and failure history of gemcitabine-based chemotherapy, performance status (PS) 0-2, normal cardiac, hepatic, and renal function were enrolled...
December 28, 2018: Hepatobiliary & Pancreatic Diseases International: HBPD INT
https://read.qxmd.com/read/30537458/adjuvant-therapy-for-biliary-tract-cancers
#6
Anne M Horgan, Jennifer J Knox
Biliary tract cancers, including gallbladder cancer, intrahepatic, perihilar, and distal cholangiocarcinomas, although anatomically contiguous, represent a heterogeneous group of cancers with extensive biologic and genetic diversity. With early disease, surgical resection is the preferred option for all subtypes; however, relapse rates remain high, and survival outcomes are poor. Data to guide the use of adjuvant therapy have been limited to retrospective series, population-based studies, and meta-analyses, all with their associated limitations...
December 2018: Journal of Oncology Practice
https://read.qxmd.com/read/30236766/right-lobe-split-liver-graft-versus-whole-liver-transplantation-a-systematic-review-by-updated-traditional-and-cumulative-meta-analysis
#7
REVIEW
Paschalis Gavriilidis, Keith J Roberts, Daniel Azoulay
INTRODUCTION: Advancements in surgical techniques and experience of donor-recipient pairing has led to a wider use of right split liver grafts in adults. An update meta-analysis was conducted to compare right split liver graft (RSLG) and whole liver transplantation (WLT) using traditional and cumulative approaches. METHODS: Databases were searched for relevant articles over the previous 20 years (MEDLINE, Embase, Cochrane Library, and Google Scholar). Meta-analyses were performed using both fixed and random effects models...
September 3, 2018: Digestive and Liver Disease
https://read.qxmd.com/read/29887343/incidence-of-cancer-other-than-gastric-cancer-in-pernicious-anaemia-a-systematic-review-with-meta-analysis
#8
REVIEW
Edith Lahner, Marina Capasso, Marilia Carabotti, Bruno Annibale
BACKGROUND: Pernicious anaemia (PA) is associated with increased gastric cancer risk, but the evidence is conflicting regarding the associated risk of other cancers. AIM: To systematically determine the incidence rates of gastro-intestinal cancers other than gastric cancers (GI-other-than-GC) and non-gastrointestinal cancers (non-GIC) in PA adults, globally and per tumour site, and the risk associated with PA for GI-other than GC and non-GIC. METHODS: Studies of PA patients reporting the incidence of GI-other-than-GCs and non-GICs were identified with MEDLINE (PubMed)-EMBASE (from first date available to April 2017)...
August 2018: Digestive and Liver Disease
https://read.qxmd.com/read/29721058/egfr-target-therapy-combined-with-gemox-for-advanced-biliary-tract-cancers-a-meta-analysis-based-on-rcts
#9
Wen Cai, Ying Yuan, Weiting Ge, Yu Fan, Xue Liu, Dehao Wu, Hanguang Hu
Background: Controversy exists regarding whether EGFR-targeted therapy combined with GEMOX (gemcitabine and oxaliplatin) provides additional benefits over GEMOX alone for biliary tract cancer patients. Therefore, this meta-analysis of randomized controlled trials (RCTs) was performed to assess the efficacy and safety of the GEMOX + EGFR-targeted regimen, and subgroup analysis was conducted to identify groups that might benefit from targeted therapy. Methods: The PubMed, Cochrane Library, and ClinicalTrials...
2018: Journal of Cancer
https://read.qxmd.com/read/29706374/risk-of-gastrointestinal-cancers-in-patients-with-cystic-fibrosis-a-systematic-review-and-meta-analysis
#10
Akihiro Yamada, Yuga Komaki, Fukiko Komaki, Dejan Micic, Samantha Zullow, Atsushi Sakuraba
BACKGROUND: The management and life expectancy of patients with cystic fibrosis have improved substantially in the past three decades, which has resulted in an increased number of these patients being diagnosed with malignancies. Our aim was to assess the risk of gastrointestinal cancers in patients with cystic fibrosis. METHODS: In this systematic review and meta-analysis, we searched PubMed, MEDLINE, Google Scholar, Scopus, Embase, and Cochrane databases with no language restrictions for studies published from inception of the databases to Aug 1, 2017, assessing the risk of gastrointestinal cancers in patients with cystic fibrosis...
June 2018: Lancet Oncology
https://read.qxmd.com/read/29578146/human-epidermal-growth-factor-receptor-2-epidermal-growth-factor-receptor-and-c-met-overexpression-and-survival-in-biliary-tract-cancer-a-meta-analysis
#11
Wei Zhou, Congqing Jiang, Nan Zhan, Xiaoguang Lv, Lifang Fan, Maskey Ninu
Background: Tyrosine kinase growth factor receptors (TKGFRs) play an important role in the progression of cancer. A variety of studies have investigated the clinicopathologic correlation of these receptors and their influences on patient survival in different types of cancer. As the members of TKGFRs, the biomarkers c-MET, epidermal growth factor receptor (EGFR), and human epidermal growth factor receptor 2 (HER-2) have been extensively investigated in biliary tract cancer (BTC). However, their prognostic value is still controversial...
2018: Journal of Cancer Research and Therapeutics
https://read.qxmd.com/read/29557418/the-diagnostic-value-of-pyruvate-kinase-isoenzyme-type-m2-for-biliary-tract-carcinoma-a-systematic-review-and-meta-analysis
#12
Wen Qin Wang, Wei Liu, Ning Zhang, Peng Hui Wang, Jian Zhong Cao, Jie Min Chen, Bing Lu Li, Xiao Dong He
BACKGROUND AND AIMS: Growing evidence has shown that M2-PK is involved in cancer diagnosis and prognosis. The overall diagnostic accuracy of the pyruvate kinase isoenzyme type M2 (M2-PK) in biliary tract carcinoma (BTC) remains controversial. We performed a meta-analysis to evaluate the diagnostic value of M2-PK for BTC. METHODS: The online PubMed, Cochrane, Web of Science, and Embase databases were searched for eligible studies published until August 8th, 2017...
March 2018: Journal of Gastrointestinal and Liver Diseases: JGLD
https://read.qxmd.com/read/29473717/interventions-for-paracetamol-acetaminophen-overdose
#13
REVIEW
Angela L Chiew, Christian Gluud, Jesper Brok, Nick A Buckley
BACKGROUND: Paracetamol (acetaminophen) is the most widely used non-prescription analgesic in the world. Paracetamol is commonly taken in overdose either deliberately or unintentionally. In high-income countries, paracetamol toxicity is a common cause of acute liver injury. There are various interventions to treat paracetamol poisoning, depending on the clinical status of the person. These interventions include inhibiting the absorption of paracetamol from the gastrointestinal tract (decontamination), removal of paracetamol from the vascular system, and antidotes to prevent the formation of, or to detoxify, metabolites...
February 23, 2018: Cochrane Database of Systematic Reviews
https://read.qxmd.com/read/29413685/picca-study-panitumumab-in-combination-with-cisplatin-gemcitabine-chemotherapy-in-kras-wild-type-patients-with-biliary-cancer-a-randomised-biomarker-driven-clinical-phase-ii-aio-study
#14
RANDOMIZED CONTROLLED TRIAL
Arndt Vogel, Stefan Kasper, Michael Bitzer, Andreas Block, Marianne Sinn, Henning Schulze-Bergkamen, Markus Moehler, Nicole Pfarr, Volker Endris, Benjamin Goeppert, Kirsten Merx, Elisabeth Schnoy, Jens T Siveke, Patrick Michl, Dirk Waldschmidt, Jan Kuhlmann, Michael Geissler, Christoph Kahl, Ralph Evenkamp, Torben Schmidt, Alexander Kuhlmann, Wilko Weichert, Stefan Kubicka
BACKGROUND: Combination chemotherapy has shown benefit in the treatment of biliary cancer and further improvements might be achieved by the addition of a biological agent. We report here the effect of chemotherapy with the monoclonal EGFR antibody panitumumab as therapy for KRAS wild-type biliary cancer. PATIENTS AND METHODS: Patients with advanced biliary tract cancer were randomised (2:1) to receive cisplatin 25 mg/m2 and gemcitabine 1000 mg/m2 on day 1 and day 8/q3w with (arm A) or without panitumumab (arm B; 9 mg/kg BW, i...
March 2018: European Journal of Cancer
https://read.qxmd.com/read/29246010/the-efficacy-and-safety-of-different-pharmacological-interventions-for-patients-with-advanced-biliary-tract-cancer-a-network-meta-analysis
#15
Xin-Fang Sun, Zhi-Kuan He, Jin-Ping Sun, Quan-Xing Ge, Er-Dong Shen
Biliary tract cancer (BTC) is the second common cancer in liver cancer. Chemotherapy is the mainstay of treatments for patients with advanced or metastatic disease, while fluorouracil (FU)-based and gemcitabine (GEM)-based treatments are most widely applied. This NMA aimed to figure out whether the addition of platinum (PLA) and target agents (TAR) can influence the efficacy and safety of standard chemotherapy. Network meta-analysis (NMA) was conducted based on the records from PubMed, Embase and Cochrane. Eligible data was extracted from available qualified trials and outcomes...
November 21, 2017: Oncotarget
https://read.qxmd.com/read/29069029/best-option-for-preoperative-biliary-drainage-in-klatskin-tumor-a-systematic-review-and-meta-analysis
#16
REVIEW
Zengwei Tang, Yuan Yang, Wenbo Meng, Xun Li
The operative treatment combined with preoperative biliary drainage (PBD) has been established as a safe Klatskin tumor (KT) treatment strategy. However, there has always been a dispute for the preferred technique for PBD technique. This meta-analysis was conducted to compare the biliary drainage-related cholangitis, pancreatitis, hemorrhage, and the success rates of palliative relief of cholestasis between percutaneous transhepatic biliary drainage (PTBD) and endoscopic biliary drainage (EBD), to identify the best technique in the management of KT...
October 2017: Medicine (Baltimore)
https://read.qxmd.com/read/28903023/platelet-to-lymphocyte-ratio-in-biliary-tract-cancer-review-and-meta-analysis
#17
REVIEW
Lin-Hua Zhou, Xiao-Feng Luo
BACKGROUND: The platelet to lymphocyte ratio (PLR) has been found to predict clinical outcomes in multiple malignancies. The aim of this study was to assess the prognostic value of pretreatment PLR in biliary tract cancer (BTC). METHODS: We searched the MEDLINE, EMBASE, and Cochrane databases to identify studies evaluating the prognostic significance of pretreatment PLR in BTC. The end points were overall survival (OS), recurrence-free survival (RFS). Pooled hazard ratios (HRs) or odds ratios (ORs) with 95% confidence intervals (CIs) were calculated using fixed-effects/random-effects models...
November 2017: Clinica Chimica Acta; International Journal of Clinical Chemistry
https://read.qxmd.com/read/28885493/systematic-review-and-meta-analysis-of-posttransplant-hepatic-artery-and-biliary-complications-in-patients-treated-with-transarterial-chemoembolization-before-liver-transplantation
#18
REVIEW
Dimitri Sneiders, Thymen Houwen, Liset H M Pengel, Wojciech G Polak, Frank J M F Dor, Hermien Hartog
BACKGROUND: Hepatic artery complications are feared complications after liver transplantation and may compromise the biliary tract, graft, and patient survival. The objective of this systematic review and meta-analysis was to compare risk of hepatic artery and biliary complications after liver transplantation in patients who underwent neoadjuvant transarterial chemoembolization (TACE) versus no TACE. METHODS: Comprehensive searches were performed in Embase, MEDLINE OvidSP, Web of Science, Google Scholar, and Cochrane databases to identify studies concerning hepatocellular cancer patients undergoing preliver transplantation TACE...
January 2018: Transplantation
https://read.qxmd.com/read/28846640/coffee-consumption-and-risk-of-biliary-tract-cancers-and-liver-cancer-a-dose-response-meta-analysis-of-prospective-cohort-studies
#19
Justyna Godos, Agnieszka Micek, Marina Marranzano, Federico Salomone, Daniele Del Rio, Sumantra Ray
BACKGROUND: A meta-analysis was conducted to summarize the evidence from prospective cohort and case-control studies regarding the association between coffee intake and biliary tract cancer (BTC) and liver cancer risk. METHODS: Eligible studies were identified by searches of PubMed and EMBASE databases from the earliest available online indexing year to March 2017. The dose-response relationship was assessed by a restricted cubic spline model and multivariate random-effect meta-regression...
August 28, 2017: Nutrients
https://read.qxmd.com/read/28839445/laparoscopic-ultrasonography-as-an-alternative-to-intraoperative-cholangiography-during-laparoscopic-cholecystectomy
#20
REVIEW
Alexandra Dili, Claude Bertrand
AIM: To assess the role of laparoscopic ultrasound (LUS) as a substitute for intraoperative cholangiography (IOC) during cholecystectomy. METHODS: We present a MEDLINE and PubMed literature search, having used the key-words "laparoscopic intraoperative ultrasound" and "laparoscopic cholecystectomy". All relevant English language publications from 2000 to 2016 were identified, with data extracted for the role of LUS in the anatomical delineation of the biliary tract, detection of common bile duct stones (CBDS), prevention or early detection of biliary duct injury (BDI), and incidental findings during laparoscopic cholecystectomy...
August 7, 2017: World Journal of Gastroenterology: WJG
keyword
keyword
164501
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"